Facebook Twitter LinkedIn Google Plus RSS

Actavis, Valeant announce marketing deal

By ,

Actavis Inc., in Parsippany, announced today it will exclusively market a generic version Zovirax for Valeant Pharmaceuticals International Inc.

In addition, Valeant has granted Actavis the exclusive right to co-promote Zovirax cream to obstetricians and gynecologists in the United States, and Actavis has granted Valeant the exclusive right to co-promote its Cordran product in the United States. Terms were not disclosed.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!